Skip to Content
Home > About Us > Research and Grants Administration > Results
This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair.
View Additional Section Content
For more information about our research program and IRB, please contact: